Posted on: 14 March, 2024
Researchers based at the Kolling Institute have launched a clinical trial using digital health technology to help those with chronic pain reduce their use of opioids.
Chief investigator and leading pain specialist at Royal North Shore Hospital Professor Paul Glare said many people with chronic pain are using opioid medications long-term, but research shows that in many cases, these medic.....
Read more
Category: Neuroscience and Pain Research, New Treatment
Posted on: 08 March, 2024
It has taken three years and many hours of careful work, but two researchers from the John Walsh Centre for Rehabilitation Research have developed the first clinical practice guidelines for physiotherapists to inform the care of people with life-changing spinal cord injuries.
Physiotherapy is a key part of rehabilitation for people with a spinal cord injury, but until now, there has been.....
Read more
Category: Neuroscience and Pain Research, New Treatment, Research Excellence
Posted on: 12 October, 2023
For the thousands of people who undergo a total knee replacement each year, a new technological approach may hold the key to a better recovery following surgery.
Researchers from the Kolling Institute conducted a randomized clinical trial, investigating whether a digital technology package delivered remotely was effective in reducing pain and improving mobility after a knee replacement.
.....
Read more
Category: Musculoskeletal Research, New Treatment, Research Excellence
Posted on: 26 July, 2023
With a concerning rise in the number of people developing Type 2 diabetes, our researchers at the Kolling Institute are offering hope and an effective way forward to reduce the impact of the serious disease.
Type 2 diabetes is the fastest growing chronic disease in the world, and if the current trend continues, it’s anticipated close to three million Australians will have the disease by .....
Read more
Category: Cardiovascular and Renal Research, New Treatment, Research Excellence
Posted on: 17 July, 2023
With the number of people living with low back pain escalating sharply, researchers are turning to widely-accessible technology to reduce the impact of the disabling condition.
The team from the University of Sydney and the Kolling Institute has launched a study measuring the effectiveness of a mobile health program which offers self-management strategies via text messages.
Study lead Pr.....
Read more
Category: Musculoskeletal Research, New Treatment, Research Excellence
Posted on: 14 July, 2023
The expertise across Australia’s space medicine community was showcased during a special event co-ordinated by the Kolling Institute and the Australasian Society of Aerospace Medicine.
Staged over two days, the colloquium involved national and international experts including representatives from the Australian Space Agency, the CSIRO, Boeing and the Australian Antarctic Program.
Presente.....
Read more
Category: New Treatment, Research Excellence
Posted on: 09 May, 2023
Researchers based at Royal North Shore Hospital have launched the first study of its kind in the world to support those with a spinal cord injury.
The team from the Kolling Institute’s John Walsh Centre for Rehabilitation Research is now seeking recruits for the clinical trial which is investigating the benefits of an approach combining breathing techniques with heart rate feedback.
Stud.....
Read more
Category: New Treatment, Research Excellence
Posted on: 13 March, 2023
With ovarian cancer continuing to have a devastating outcome for many women, new research at the Kolling Institute is offering hope.
The disease has the lowest survival rate of any women’s cancer, with only 48 per cent of women living beyond five years after diagnosis.
Ovarian cancer is often diagnosed late because the symptoms are vague, like bloating, nausea, indigestion, excessive tir.....
Read more
Category: New Treatment, Research Excellence
Posted on: 07 December, 2022
Generous funding provided through the Douglas and Lola Douglas scholarship is strengthening evidence around the long term impacts on children born to mothers with obesity and gestational diabetes.
Endocrinologist and Kolling Institute researcher Dr Tessa Weir has been able to continue her valuable research as a result of being awarded the scholarship.
“I am incredibly grateful for t.....
Read more
Category: Cardiovascular and Renal Research, New Treatment, Research Excellence
Posted on: 11 November, 2022
Kolling researcher and Royal North Shore Hospital endocrinologist Associate Professor Sarah Glastras will have a key role in a national effort to improve long-term outcomes for those with diabetes.
The initiative has brought dozens of experts from across the country together under the banner of the Australian Centre for Accelerating Diabetes Innovations Research.
International collaborat.....
Read more
Category: Cardiovascular and Renal Research, New Treatment, Research Excellence